A citation-based method for searching scientific literature

Renata D'Alpino Peixoto, Duilio R Rocha-Filho, Rui F Weschenfelder, Juliana F M Rego, Rachel Riechelmann, Anelisa K Coutinho, Gustavo S Fernandes, Alexandre A Jacome, Aline C Andrade, Andre M Murad, Celso A L Mello, Diego S C G Miguel, Diogo B D Gomes, Douglas J Racy, Eduardo D Moraes, Eduardo H Akaishi, Elisangela S Carvalho, Evandro S Mello, Fauze Maluf Filho, Felipe J F Coimbra, Fernanda C Capareli, Fernando F Arruda, Fernando M A C Vieira, Flavio R Takeda, Guilherme C C Cotti, Guilherme L S Pereira, Gustavo A Paulo, Héber S C Ribeiro, Laercio G Lourenco, Marcela Crosara, Marcelo G Toneto, Marcos B Oliveira, Maria de Lourdes Oliveira, Maria Dirlei Begnami, Nora M Forones, Osmar Yagi, Patricia Ashton-Prolla, Patricia B Aguillar, Paulo C G Amaral, Paulo M Hoff, Raphael L C Araujo, Raphael P Di Paula Filho, Rene C Gansl, Roberto A Gil, Tulio E F Pfiffer, Tulio Souza, Ulysses Ribeiro Jr, Victor Hugo F Jesus, Wilson L Costa Jr, Gabriel Prolla. Ecancermedicalscience 2020
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Incidence and Mortality Rates and Trends--An Update.
Lindsey A Torre, Rebecca L Siegel, Elizabeth M Ward, Ahmedin Jemal. Cancer Epidemiol Biomarkers Prev 2016
100

Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis.
Kamal Nagpal, Kamran Ahmed, Amit Vats, Danny Yakoub, David James, Hutan Ashrafian, Ara Darzi, Krishna Moorthy, Thanos Athanasiou. Surg Endosc 2010
217
50

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
F Noble, M A Lloyd, R Turkington, E Griffiths, M O'Donovan, J R O'Neill, S Mercer, S L Parsons, R C Fitzgerald, T J Underwood. Br J Surg 2017
41
50


Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine.
Philippe Lambin, Jaap Zindler, Ben Vanneste, Lien van de Voorde, Maria Jacobs, Daniëlle Eekers, Jurgen Peerlings, Bart Reymen, Ruben T H M Larue, Timo M Deist,[...]. Acta Oncol 2015
48
50

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.
Nicholas J Shaheen, Gary W Falk, Prasad G Iyer, Lauren B Gerson. Am J Gastroenterol 2016
714
50

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki,[...]. Lancet Oncol 2019
182
50


Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, Harald Schmalenberg, Stephan Hollerbach, Ralf Hofheinz, Volker Rethwisch, Gernot Seipelt, Nils Homann, Gerhard Wilhelm,[...]. J Clin Oncol 2008
498
50

A prospective study of combined therapy in esophageal cancer.
C Apinop, P Puttisak, N Preecha. Hepatogastroenterology 1994
252
50

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
894
50

High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality?
R Metzger, E Bollschweiler, D Vallböhmer, M Maish, T R DeMeester, A H Hölscher. Dis Esophagus 2004
138
50

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett's esophagus and esophageal adenocarcinoma.
A M J van Nistelrooij, R van Marion, W F J van Ijcken, A de Klein, A Wagner, K Biermann, M C W Spaander, J J B van Lanschot, W N M Dinjens, B P L Wijnhoven. Fam Cancer 2018
2
50

Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
Sheraz Markar, Caroline Gronnier, Alain Duhamel, Arnaud Pasquer, Jérémie Théreaux, Mael Chalret du Rieu, Jérémie H Lefevre, Kathleen Turner, Guillaume Luc, Christophe Mariette. J Clin Oncol 2015
96
50

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.
D H Ilson, L Saltz, P Enzinger, Y Huang, A Kornblith, M Gollub, E O'Reilly, G Schwartz, J DeGroff, G Gonzalez,[...]. J Clin Oncol 1999
200
50

DNA topoisomerase I-targeting drugs as radiation sensitizers.
A Y Chen, H Choy, M L Rothenberg. Oncology (Williston Park) 1999
55
50

Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction.
J A Ajani, J A Roth, J B Putnam, G Walsh, P M Lynch, L D Roubein, M B Ryan, G Natrajan, P Gould. Eur J Cancer 1995
16
50

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
David Cunningham, William H Allum, Sally P Stenning, Jeremy N Thompson, Cornelis J H Van de Velde, Marianne Nicolson, J Howard Scarffe, Fiona J Lofts, Stephen J Falk, Timothy J Iveson,[...]. N Engl J Med 2006
50

Hospital volume and surgical mortality in the United States.
John D Birkmeyer, Andrea E Siewers, Emily V A Finlayson, Therese A Stukel, F Lee Lucas, Ida Batista, H Gilbert Welch, David E Wennberg. N Engl J Med 2002
50

Preoperative chemoradiotherapy for esophageal or junctional cancer.
P van Hagen, M C C M Hulshof, J J B van Lanschot, E W Steyerberg, M I van Berge Henegouwen, B P L Wijnhoven, D J Richel, G A P Nieuwenhuijzen, G A P Hospers, J J Bonenkamp,[...]. N Engl J Med 2012
50

Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study.
B E Chatterton, I Ho Shon, A Baldey, N Lenzo, A Patrikeos, B Kelley, D Wong, J E Ramshaw, A M Scott. Eur J Nucl Med Mol Imaging 2009
53
50

Prognostic Relevance of Lymph Node Regression After Neoadjuvant Chemoradiation for Esophageal Cancer.
Annouck Philippron, Elfriede Bollschweiler, Ayumi Kunikata, Patrick Plum, Claudia Schmidt, Francesco Favi, Uta Drebber, Arnulf H Hölscher. Semin Thorac Cardiovasc Surg 2016
19
50

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.
Robert J Downey, Tim Akhurst, David Ilson, Robert Ginsberg, Manjit S Bains, Mithat Gonen, Heng Koong, Marc Gollub, Bruce D Minsky, Maureen Zakowski,[...]. J Clin Oncol 2003
240
50

Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis.
Dong-Bin Wang, Xun Zhang, Hong-Li Han, Yi-Jun Xu, Da-Qiang Sun, Zhen-Liang Shi. Dig Dis Sci 2012
31
50


Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.
Manish A Shah, Yelena Y Janjigian, Ronald Stoller, Stephen Shibata, Margaret Kemeny, Smitha Krishnamurthi, Yungpo Bernard Su, Allyson Ocean, Marinela Capanu, Bhoomi Mehrotra,[...]. J Clin Oncol 2015
102
50

Capecitabine and oxaliplatin for advanced esophagogastric cancer.
David Cunningham, Naureen Starling, Sheela Rao, Timothy Iveson, Marianne Nicolson, Fareeda Coxon, Gary Middleton, Francis Daniel, Jacqueline Oates, Andrew Richard Norman. N Engl J Med 2008
50



Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.
William H Allum, Sally P Stenning, John Bancewicz, Peter I Clark, Ruth E Langley. J Clin Oncol 2009
595
50


ESOPHAGEAL CARCINOMA: IS SQUAMOUS CELL CARCINOMA DIFFERENT DISEASE COMPARED TO ADENOCARCINOMA? A transversal study in a quaternary high volume hospital in Brazil.
Francisco Tustumi, Flavio Roberto Takeda, Cintia Mayumi Sakurai Kimura, Rubens Antônio Aissar Sallum, Ulysses Ribeiro, Ivan Cecconello. Arq Gastroenterol 2016
9
50

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Kohei Shitara, Eric Van Cutsem, Yung-Jue Bang, Charles Fuchs, Lucjan Wyrwicz, Keun-Wook Lee, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee,[...]. JAMA Oncol 2020
73
50

Fluoropyrimidine-Radiation Interactions in Cells and Tumors.
Lawrence, Tepper, Blackstock. Semin Radiat Oncol 1997
38
50

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
Laurent Bedenne, Pierre Michel, Olivier Bouché, Chantal Milan, Christophe Mariette, Thierry Conroy, Denis Pezet, Bernard Roullet, Jean-François Seitz, Jean-Philippe Herr,[...]. J Clin Oncol 2007
760
50

Salvage esophagectomy following definitive chemoradiotherapy.
Mitsuyo Nishimura, Hiroyuki Daiko, Junji Yoshida, Kanji Nagai. Gen Thorac Cardiovasc Surg 2007
35
50

Minimally invasive versus open esophagectomy: meta-analysis of outcomes.
George Sgourakis, Ines Gockel, Arnold Radtke, Thomas J Musholt, Stephan Timm, Andreas Rink, Achilleas Tsiamis, Constantine Karaliotas, Hauke Lang. Dig Dis Sci 2010
110
50

Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
J A Ajani, J A Roth, B Ryan, M McMurtrey, T A Rich, D E Jackson, J L Abbruzzese, B Levin, L DeCaro, C Mountain. J Clin Oncol 1990
96
50


Assessment of a HER2 scoring system for gastric cancer: results from a validation study.
M Hofmann, O Stoss, D Shi, R Büttner, M van de Vijver, W Kim, A Ochiai, J Rüschoff, T Henkel. Histopathology 2008
771
50

Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma.
Rami J Badreddine, Ganapathy A Prasad, Jason T Lewis, Lori S Lutzke, Lynn S Borkenhagen, Kelly T Dunagan, Kenneth K Wang. Clin Gastroenterol Hepatol 2010
63
50

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.
A Herskovic, K Martz, M al-Sarraf, L Leichman, J Brindle, V Vaitkevicius, J Cooper, R Byhardt, L Davis, B Emami. N Engl J Med 1992
50


Detection of distant metastases in esophageal cancer with (18)F-FDG PET.
Pierre A M Heeren, Pieter L Jager, Fons Bongaerts, Hendrik van Dullemen, Wim Sluiter, John Th M Plukker. J Nucl Med 2004
95
50

Staging investigations for oesophageal cancer: a meta-analysis.
E P M van Vliet, M H Heijenbrok-Kal, M G M Hunink, E J Kuipers, P D Siersema. Br J Cancer 2008
308
50



Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience.
Humaid O Al-Shamsi, Yazan Fahmawi, Ibrahim Dahbour, Aziz Tabash, Jane E Rogers, Jeannette Elizabeth Mares, Mariela A Blum, Jeannelyn Estrella, Aurelio Matamoros, Tara Sagebiel,[...]. J Gastrointest Oncol 2016
9
50

Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial.
Jennifer Straatman, Nicole van der Wielen, Miguel A Cuesta, Freek Daams, Josep Roig Garcia, Luigi Bonavina, Camiel Rosman, Mark I van Berge Henegouwen, Suzanne S Gisbertz, Donald L van der Peet. Ann Surg 2017
174
50

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Joel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, Pieter van Hagen, Mark I van Berge Henegouwen, Bas P L Wijnhoven, Hanneke W M van Laarhoven, Grard A P Nieuwenhuijzen, Geke A P Hospers, Johannes J Bonenkamp,[...]. Lancet Oncol 2015
991
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.